The first total syntheses of Balsacone C (16) and Balsacone B (17), mainly based on a convergent strategy, were described. The crucial step of this strategy was the alkylation of trihydroxydihydrochalcone derivatives 7 and 8 with cinnamyl bromide derivative 13. For this, compounds 7 and 8 were prepared starting from trihydroxyacetophenone (1) in four steps. Then compound 13 was prepared starting from coumaric acid (9) in four steps.
INTRODUCTION
Due to the increasing antibiotic resistance among bacterial species, there is an increasing demand to discover new antibacterial compounds (1) . Although microbial secondary metabolites, to date, are the major source of new antibiotics, only two novel antibiotic classes have led to the development of alternative strategies within the last 50 years (2) . Natural products originating from plants are considered as the source of new compounds with potential antibiotic properties (3) . The use of herbal sources for the treatment of bacterial infections has been a very common practice in traditional medicine worldwide (4) (5) (6) (7) .
Populus balsamifera L. belonging to the Salicaceae family is a tree growing in almost all regions in North America. There are many studies reporting the use of P. balsamifera L.
buds by native Canadians in traditional medicine. For example, these plant species have been used for treating dermatological and gastrointestinal conditions (8) . Moreover, the Canadian native population has prepared ointment from the buds of this plant, used it for treating wounds, and reported that this ointment has protective effects against infections (8) . Phytochemical studies that were previously conducted on the buds of this plant have led to the identification of alkanes (9) , fatty acids (10), terpenes (10) , phenols (11), flavonoids (11) (12) , chalcones (11) (12) , carbohydrates (13) , and prostaglandins (13) .
Balsacones B and C, the total syntheses of which were performed within the scope of this study, were first isolated as antibacterial compounds from P. balsemifera L. by Lavoie et al. in 2013 (8) . Each of these natural products was tested against Escherichia coli (gram negative) and Staphylococcus aureus (gram positive), and both were reported to exert significant activity against S. aureus (Table 1 ) (8). In recent studies, the extracts of Populus species have been reported to have antimicrobial, antioxidant, and cytotoxic activities (14) (15) (16) . The structures of natural products for which total syntheses were performed are shown in Figure 1 . 
EXPERIMENTAL

Chemicals and Instrumentation
Chemicals and reagents were purchased from Sigma Aldrich and used without further purification. THF was purified and distilled over Na. All other solvents and reagents were used as received. The progress of the reaction was monitored via TLC, using TLC Merck silica gel 60 F254. The C-NMR spectra were recorded over 400 (100) MHz
Varian spectrometer using CDCl3, CD3OD and Acetone-d6. Column chromatography was performed on silica gel 60 (70-230 mesh ASTM). Infrared (IR) spectra were obtained from solutions in 0.1-mm cells with a Perkin-Elmer spectrometer (Waltham, MA).
2,4-Bis(methoxymethoxy)-6-hydroxyacetophenone (2)
To a solution of trihydroxyacetophenone (1) (4.8 g, 28.5 mmol) in DCM (20 mL, dry) was added DIPEA (13 mL, 82.5 mmol) dropwise at 0 °C under N2. The resulting mixture was stirred for 20 min, then MOMCl (5 mL, 82.5 mmol) was added to the mixture at the same temp. After being stirred for additional 20 min at 0 °C , the reaction mixture was diluted with EtOAc (200 mL), washed with water (50 mL), dried (Na2SO4) and concentrated.
Purification of the crude product by silica gel chromatography using EtOAc/Hexane as eluent (25%) afforded the known compound 2 as a colorless liquid (5.15 g, 71% 
2',4',6'-Trihydroxychalcone (5)
To a solution of 3 (738 mg, 2.14 mmol) in MeOH (10 mL) was added 12 M HCl solution (0.27 mL) drop by drop at room temp. Reaction mixture was stirred for 23 h. After 23 h, the reaction mixture was diluted with EtOAc (100 mL), washed with H2O (10 mL), dried (Na2SO4) and concentrated. Purification of the remaining residue by column chromatography over silica gel using gradient elution with EtOAc and hexanes (40% 
2',4',6'-Trihydroxydihydrochalcone (7)
To a solution of trihydroxychalcone 5 (435 mg, 1.69 mmol) in MeOH (15 mL), Pd/C (10%) was added. The reaction flask was purged with hydrogen gas three times before being allowed to stir under a hydrogen balloon for 4 h at room temp. Then, the reaction mixture was filtered and concentrated in vacuo to yield compound 7 as a pale yellow solid (337 mg, 77% 
2',4',6'-Trihydroxy-4-methoxydihydrochalcone (8)
To a solution of trihydroxychalcone 6 (938 mg, 3.27 mmol) in MeOH (15 mL), Pd/C (10%) was added. The reaction flask was purged with hydrogen gas three times before being allowed to stir under a hydrogen balloon for 4 h at room temp. Then, the reaction mixture was filtered and concentrated in vacuo to yield compound 8 as a white solid (862 mg, 61% C-NMR spectra of compound 8 were in agreement with the data given in the literature (21).
Methyl 4-hydroxycinnamate (10)
A solution of 9 (1 g, 6.1 mmol) in MeOH (20 mL) was treated with p-TSA (cat. amount) and refluxed for 17 h. The reaction mixture was quenched by the addition of NaHCO3 (30 mL) and extracted with EtOAc (3 x 50 mL). The combined extracts were dried (Na2SO4) and the solvent concentrated in vacuo to give the known compound 10 as a white solid (1 g, 92%). 
(E)-3-(4-(tert-Butyldimethylsilyloxy)phenyl)prop-2-en-1-ol (12)
To a solution of 11 (408 mg, 1.39 mmol) in DCM (10 mL), stirred at -78 °C, was added a 
4-(tert-Butyldimethylsiloxy)cinnamyl bromide (13)
A solution of alcohol 12 (320 mg, 1.21 mmol) in Et2O (10 mL) was cooled to 0 °C , and PBr3
(0.04 mL, 0.38 mmol) was added with a syringe. This mixture was stirred for half an hour.
After monitoring with TLC, NaCl (15 mL, saturated aqueous solution) was added to the mixture. The organic layer was then separated and concentrated. The crude product was dissolved in DCM (50 mL), dried (MgSO4) and concentrated to afford known compound 13
as a white solid (120 mg, 96%). was in agreement with the data given in the literature (24) .
Balsacone C (16)
To a solution of 7 (211 mg, 0.82 mmol) in THF (5 mL) was added NaH (41 mg, 1.02 mmol) under N2 at room temp. After stirring 5 min, compound 13 (335 mg, 1.02 mmol) was added to the mixture and the reaction was stirred at room temp. for 2 days. After monitoring with TLC, the reaction was stopped and the solvent was removed. The crude product was diluted with EtOAc (150 mL) and 2 M HCl solution was added until pH 1-2.
The organic layer was dried (Na2SO4) and the solvent was concentrated to afford compound 
Balsacone B (17)
To a solution of 8 (320 mg, 1.11 mmol) in THF (5 mL) was added NaH (55 mg, 1.39 mmol)
under N2 at room temperature. After stirring 5 min., compound 13 (456 mg, 1.39 mmol) was added to the mixture and the reaction was stirred at room temperature for 22 h. After monitoring with TLC, the reaction was stopped and the solvent was removed. The crude product was diluted with EtOAc (150 mL) and 2 M HCl solution was added until pH becomes 1-2. The organic phase was dried (Na2SO4) and the solvent was concentrated to afford compound 15. Compound 15 was used for the next step without further purification. For this, compound 15 was dissolved in THF (6 mL) and TBAF (0.28 mL, 0.28 mmol) was added to the mixture under N2 at 0 °C. The reaction mixture was stirred for 30 min. at the same temp. After monitoring with TLC, the reaction was stopped and the solvent was removed.
2 M HCl solution was added until pH 1-2 and then the mixture was extracted with EtOAc (3 x 50 mL). The combined organic phases were dried (Na2SO4) and the solvent was 
RESULTS AND DISCUSSION
The natural products, Balsacone B (17) and Balsacone C (16), contain key fragments in which simple disconnection approaches can be pursued to achieve a possible synthetic pathway. In analyzing the structures of these products we devised a strategy to first access the core trihydroxy-dihydrochalcone unit. Our synthesis is based on a convergent strategy in which the related trihydroxy-dihydrochalcone derivatives 7 and 8 were first prepared and further alkylated to yield the Balsacone structure. To the best of our knowledge, there are no reports on the total synthesis of Balsacone B (17) and Balsacone C (16 tert-Butyldimethylsilyl (TBDMS)-protected cinnamyl bromide (13) was synthesized in four steps starting from p-hydroxycinnamic acid (9) . Acid-catalyzed esterification of the phydroxycinnamic acid (9) with MeOH gave the ester derivative 10. TBDMS-protection of ester 10 gave compound 11. The reduction of the TBDMS-protected cinnamic ester 11
with DIBAL-H afforded cinnamyl alcohol 12, which was converted to cinnamyl bromide 13 via treatment with PBr3 (Scheme 2). The final step of our synthetic strategy was the alkylation of trihydroxy-dihydrochalcone derivatives 7 and 8 with compound 13. For this, alkylation of compound 7 and 8 with compound 13 in the presence of NaH gave compounds 14 and 15. After deprotection in the presence of TBAF, the target compounds Balsacone C (16) and Balsacone B (17) were obtained in a yield of 55% and 50% respectively (Scheme 3).
CONCLUSION
In summary, the first ever syntheses of natural products Balsacone B (17) and Balsacone C (16) were realized within this work. The key factor in synthesizing these natural products rested on harnessing the Friedel-Crafts alkylation reaction between cinnamylbromide 13 and dihydrochalcone derivatives 7 and 8. A straightforward alkylation in the presence of base afforded a clean product without any by-products allowing for a relatively facile approach. We envision that this method can be used to access a variety of compounds with a similar backbone and allows for simple preparation of antibacterial property containing natural products.
